Noninvasive prenatal detection of aneuploidy

Clinical Obstetrics and Gynecology

Volumn 57, Issue 1, 2014, Pages 210-225

  Robinson, Christopher ^a   Van Den Boom, Dirk ^b   Bombard, Allan T ^b,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b SEQUENOM INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

NIPT; Noninvasive prenatal testing

Indexed keywords

AMNIOCENTESIS; ANEUPLOIDY; CHORIONIC VILLI SAMPLING; DNA; DOWN SYNDROME; FEMALE; GENETIC TESTING; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84894067723     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0000000000000016     Document Type: Article

References (55)

1. Merkatz IR, Nitowsky HM, Macri JN, et al. An association between low maternal serum alphafetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol. 1984;148:886-894
2. Fuchs F, Riis P. Antenatal sex determination. Nature. 1956;177:330
3. ACOG Practice Bulletin No. 77. Screening for fetal chromosome abnormalities. Obstet Gynecol. 2007a;109:217-227
4. ACOGPractice Bulletin No. 88. Invasive prenatal testing for aneuploidy. Obstet Gynecol. 2007b;110:1459-1467
5. Boue A, Boue J. Chromosome abnormalities and abortion. In: Coutinho EM, Fuchs F eds. Physiology and Genetics of Reproduction. Part B. New York: Plenum; 1975
6. Gardner RJ, Sutherland GR. Chromosome abnormalities and Genetic Counseling. 3rd ed. New York, NY: Oxford University Press; 2004
7. ACOGCommitteeOpinionNo. 102.Management of stillbirth. Obstet Gynecol. 2009;113:748-761
8. Alberman ED, Creasy MR. Frequency of chromosome abnormalities in miscarriages and perinatal deaths. J Med Genet. 1977;14: 313-315
9. Eisenberg B, Wapner RJ. Clinical proceduress in prenatal diagnosis. Best Pract Res Clin Obstet Gynaecol. 2002;16:611-627
10. Bevis DC. The composition of liquor amnii in haemolytic disease of the newborn. J Obstet Gynaecol Br Emp. 1953;60:244-251
11. Cederqvist LL, Fuchs F. Antenatal sex determination. A historical review. Clin Obstet Gynecol. 1970;13:159-177
12. Nadler HL, Gerbie AB. Role of amniocentesis in the intrauterine detection of genetic disorders. N Engl J Med. 1970;282:596-599
13. Kullander S, Sandahl B. Fetal chromosome analysis after transcervical placental biopsies during early pregnancy. Acta Obstet Gynecol Scand. 1973;52:355-359
14. Anshan Steel Company. Fetal sex prediction by sex chromatin of chorionic villus cells during early pregnancy. Chin Med J. 1975;1:117
15. Mohr JM. Foetal genetic diagnosis: Development of techniques for early sampling of foetal cells. Acta Pathol Microbiol Scand. 1968;73:7377
16. Ward RH, Modell B, Petrou M, et al. Method of sampling chorionic villi in first trimester of pregnancy under guidance of real time ultrasound. Br Med J (Clin Res Ed). 1983;286: 1542-1544
17. Ledbetter DH, Martin AO, Verlinsky Y, et al. Cytogenetic results of chorionic villus sampling: High success rate and diagnostic accuracy in the United States collaborative study. Am J Obstet Gynecol. 1990;162:495-501
18. Worton RG, Stern R. A Canadian collaborative study of mosaicism in amniotic fluid cell cultures. Prenat Diagn. 1984;4 Spec No:131-144
19. Rhoads GG, Jackson LG, Schlesselman SE, et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med. 1989;320:609-617
20. Mazza V, Pati M, Bertucci E, et al. Age-specific risk of fetal loss post second trimester amniocentesis: Analysis of 5043 cases. Prenat Diagn. 2007;27: 180-183
21. Eddleman KA, Malone FD, Sullivan L, et al. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol. 2006;108:1067-1072
22. Tabor A, Vestergaard CH, Lidegaard O. Fetal loss rate after chorionic villus sampling and amniocentesis: An 11-year national registry study. Ultrasound Obstet Gynecol. 2009;34:19-24
23. Holmes LB. Report of National Institute of Child Health and Human Development Workshop on Chorionic Villus Sampling and Limb and Other Defects. Teratology. 1993;48:7-13
24. Malone FD, Canick JA, Ball RH, et al. Firsttrimester or second-Trimester screening, or both, for Downs syndrome. N Engl J Med. 2005;353: 2001-2011
25. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn. 1987;7:623-630
26. Ferguson-Smith MA, Yates JR. Maternal agespecific risks for chromosome aberrations and factors influencing them: Report of a collaborative European study of 52,965 amniocenteses. Prenat Diagn. 1984;4:5-44
27. Canick JA, Knight GJ, Palomaki GE, et al. Low second trimester maternal serum unconjugated oestriol in pregnancies with Downs syndrome. Br J Obstet Gynaecol. 1988;95:330-333
28. Haddow JE, Palomaki GE, Knight GJ, et al. Prenatal screening for Downs syndrome with use of maternal serum markers. N Engl J Med. 1992;327:588-593
29. Renier MA, Vereecken A, Van Herck E, et al. Second trimester maternal dimeric inhibin-A in the multiple-marker screening test for Downs syndrome. Hum Reprod. 1998;13:744-748
30. Yaron Y, Cherry M, Kramer RL, et al. Secondtrimester maternal serum marker screening: Maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol. 1999;181: 968-974
31. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485-487
32. Sayva GM, Morris JK, Mutton DE, et al. Maternal age-specific fetal loss rates in Down syndrome pregnancies. Prenat Diagn. 2006;26:499-504
33. Chiu RW, Chan KCA, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A. 2008;105:20458-20463
34. Fan HC, Blumenfeld YJ, Chitkara U, et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A. 2008;105:16266-16271
35. Chiu RW, Akolekar R, Zheng YW, et al. Noninvasive prenatal assessment of trisomy 21 by multiplexed plasma DNA sequencing: Large scale validity study. BMJ. 2011;342:c7401
36. Ehrich M, Deciu C, Zwiefelhofer T, et al. Noninvasive detection of fetal trisomy 21 by sequencing ofDNAin maternal blood: A study in a clinical setting.AmJ Obstet Gynecol. 2011;204:205.e1-11
37. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study. Genet Med. 2011;13: 913-920
38. Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: An international collaborative study. Genet Med. 2012;14:296-305
39. Canick JA, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat Diagn. 2012;32:1-5
40. Bombard AT, McCullough RM, Hicks SC, et al. Noninvasive Prenatal Testing (NIPT) in Multiple Gestations: A Report of Laboratory Experience. New Orleans, LA: American College of Obstetricians & Gynecologists Annual Meeting; 2013
41. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol. 2012;119:890-901
42. Lau TK, Chen F, Pan X, et al. Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies bymaternal plasmaDNAsequencing. JMatern Fetal Neonatal Med. 2012;25:1370-1374
43. Dan S, Wang W, Ren J, et al. Clinical application of massively parallel-sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn. 2012;9:1-8
44. Sparks AB, Wang ET, Struble CA, et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn. 2012;32:1-7
45. Sparks AB, Struble CA, Wang ET, et al. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: Evaluation for Trisomy 21 and Trisomy 18. Am J Obstet Gynecol. 2012;206:319.e1-9
46. Ashoor G, Syngelaki A, Wagner M, et al. Chromosome-selective sequencing of maternal plasma cell-free DNA for first trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol. 2012;206:322-323
47. Norton ME, Brar H, Weiss J, et al. Non-Invasive chromosomal evaluation (NICE) study: Results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy18.AmJObstetGynecol. 2012;207:137-139
48. Zimmermann B, Hill M, Gemelos G, et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn. 2012;32:1-9
49. Lo YM. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Science Transl Med. 2010;2: 61ra91
50. Mazloom AR, Dzakula Z, Wang H, et al. Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free fetal DNA from maternal plasma. Prenat Diagn. 2013;33:591-597
51. Saldivar JS. Noninvasive prenatal testing for fetal chromosome abnormalities.Special Symposium. Am Coll Med Genet Annual Meeting. Phoenix, AZ. 2013
52. Peters D, Chu T, Yatsenko SA, et al. Noninvasive prenatal diagnosis of fetal microdeletions syndrome. N Engl J Med. 2011;365:1847-1848
53. Jensen TJ, Dzakula Z, Deciu C, et al. Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma. Clin Chem. 2012;58:1148-1151
54. Yu SC, Jiang P, Choy KW, et al. Noninvasive prenatal molecular karyotyping from maternal plasma. Plos One. 2013;8:e60968
55. ACOG Committee Opinion No. 545. Noninvasive testing for fetal aneuploidy. Obstet Gynecol. 2012;120:1532-1534